BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 29500631)

  • 1. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
    Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
    Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
    Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
    Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
    Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
    N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan.
    Nanmoku K; Owada Y; Oshiro Y; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Sakuma Y; Ishikawa N; Ohkohchi N; Okamoto H; Yagisawa T
    Transpl Infect Dis; 2019 Apr; 21(2):e13033. PubMed ID: 30481402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection with hepatitis E virus in kidney transplant recipients in southeastern France.
    Moal V; Legris T; Burtey S; Morange S; Purgus R; Dussol B; Garcia S; Motte A; Gérolami R; Berland Y; Colson P
    J Med Virol; 2013 Mar; 85(3):462-71. PubMed ID: 23239466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
    Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
    Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Hepatitis E Viral Infection After Liver Transplantation: A Regression of Fibrosis After Antiviral Therapy.
    Mazzola A; Tran Minh M; Charlotte F; Hdiji A; Bernard D; Wendum D; Calmus Y; Conti F
    Transplantation; 2017 Sep; 101(9):2083-2087. PubMed ID: 28376032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.
    Kamar N; Rostaing L; Abravanel F; Garrouste C; Lhomme S; Esposito L; Basse G; Cointault O; Ribes D; Nogier MB; Alric L; Peron JM; Izopet J
    Gastroenterology; 2010 Nov; 139(5):1612-8. PubMed ID: 20708006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric liver transplanted patients and prevalence of hepatitis E virus.
    Laverdure N; Scholtès-Brunel C; Rivet C; Heissat S; Restier L; Bacchetta J; Boillot O; Dumortier J; Lachaux A
    J Clin Virol; 2015 Aug; 69():22-6. PubMed ID: 26209371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
    Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients--a single-center experience.
    Hoerning A; Hegen B; Wingen AM; Cetiner M; Lainka E; Kathemann S; Fiedler M; Timm J; Wenzel JJ; Hoyer PF; Gerner P
    Pediatr Transplant; 2012 Nov; 16(7):742-7. PubMed ID: 22738211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First report and molecular characterization of hepatitis E virus infection in renal transplant recipients in Brazil.
    Passos AM; Heringer TP; Medina-Pestana JO; Ferraz ML; Granato CF
    J Med Virol; 2013 Apr; 85(4):615-9. PubMed ID: 23382036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis E virus RNA and antibodies in a cohort of kidney transplant recipients in Central Brazil.
    de Oliveira JMNS; Freitas NR; Teles SA; Bottino FO; Lemos AS; de Oliveira JM; de Paula V; Pinto MA; Martins RMB
    Int J Infect Dis; 2018 Apr; 69():41-43. PubMed ID: 29408465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hepatitis e in heart transplant recipients.
    Pischke S; Stiefel P; Franz B; Bremer B; Suneetha PV; Heim A; Ganzenmueller T; Schlue J; Horn-Wichmann R; Raupach R; Darnedde M; Scheibner Y; Taubert R; Haverich A; Manns MP; Wedemeyer H; Bara CL
    Am J Transplant; 2012 Nov; 12(11):3128-33. PubMed ID: 22823202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis E Virus Infection in Lung Transplant Recipients: A Case Series.
    Ambrocio GPL; Aguado S; Carrillo J; Laporta R; Lazaro-Carrasco M; Avellon A; Aran-Toha G; Ussetti M; Aguilar M
    Transplant Proc; 2019 Mar; 51(2):376-379. PubMed ID: 30879545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation.
    Affeldt P; Di Cristanziano V; Grundmann F; Wirtz M; Kaiser R; Benzing T; Stippel D; Kann M; Kurschat C
    Immun Inflamm Dis; 2021 Jun; 9(2):513-520. PubMed ID: 33559399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
    von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
    J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribavirin therapy of hepatitis E infection may cause hyporegenerative anemia in pediatric renal transplant patients.
    Klämbt V; Panning M; Seidl M; Häffner K; Pohl M
    Pediatr Transplant; 2018 Jun; 22(4):e13195. PubMed ID: 29665156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Treatment of Chronic Hepatitis E After an Orthotopic Liver Transplant With Ribavirin Monotherapy.
    Klein F; Neuhaus R; Hofmann J; Rudolph B; Neuhaus P; Bahra M
    Exp Clin Transplant; 2015 Jun; 13(3):283-6. PubMed ID: 24779678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.